Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

This Sources Sought opportunity from Department Of Veterans Affairs was posted on May 1, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Blood Sample Protein Measurement Analysis

Closed
36C24526Q0481Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541715
New
Federal
Aeronautics and Spaceflight Systems Engineering Support Services (ASSESS) IIThe Aeronautics and Spaceflight Systems Engineering Support Services (ASSESS) II contract focuses on providing research, technology development, and engineering support to advance NASA’s aircraft and spaceflight system missions. This contract covers a broad range of activities including scientific research, engineering design and analysis, advancing technology readiness levels, managing and implementing technology programs, conducting tests and operations, and supporting program and project management efforts. The work aims to adapt and enhance capabilities to meet evolving NASA mission requirements, ensuring continued innovation and technical progress in aeronautics and spaceflight systems. The contract is forecasted to be performed primarily at Moffett Field and falls under the NAICS code 541715, which relates to research and development services. While details about set-aside status are yet to be determined, the contract offers opportunities for various types of organizations to participate. Points of contact for the contract are Mary E. Livingston and Robert E. Watts, who serve as the main liaison and small business specialist respectively. This contract underscores NASA’s commitment to advancing scientific and engineering frontiers through comprehensive support of aeronautics and spaceflight system development.
Ames Research Center

POSTED

in almost 3 years

DEADLINE

N/A

AI Contract Overview

Show more

The Department of Veterans Affairs (VA), through the Washington DC VA Medical Center (DC VAMC), is seeking sources for a prospective biospecimen collection and clinical data repository study focused on advanced prostate cancer among Veterans. This study addresses the critical need for validated circulating biomarkers that can better predict treatment response and early disease progression, surpassing current reliance on PSA kinetics and imaging. The contract involves processing approximately 120 coded frozen plasma aliquots collected longitudinally from roughly 24 study participants. The vendor is required to perform high-plex proteomic analysis using the SomaScan assay platform under CLIA certification, adhering to established VA biospecimen handling protocols, including storage and shipment at –80°C. The vendor will thaw, prepare samples according to standard operating procedures, conduct assays with quality control measures, and deliver standardized proteomic data files (ADAT format) and quality assurance documentation back to the VA. Unused specimens must be returned to the VA after analysis. All generated data and materials will be the exclusive property of the U.S. Government. This solicitation is a firm-fixed-price contract with a base performance period plus a one-year option. The primary place of performance for the assay work is the vendor’s facility, while final data delivery and acceptance will occur at the DC VAMC. The procurement emphasizes strict compliance with federal and VA information security policies, including data segregation, secure data destruction per NARA and VA directives, and adherence to Privacy Act and FOIA regulations. Organizational conflict of interest mitigation measures include subcontractor approval requirements and restrictions on use and disclosure of VA data. The solicitation is currently a sources sought notice with no pricing or evaluation criteria disclosed. Proposals must include a capability statement, summary of relevant experience, business information including UEI, and small business status if applicable. Submissions are to be made electronically by May 15, 2026, to the designated VA point of contact. The overall effort supports exploratory biomarker research aimed at informing future precision oncology strategies tailored to Veterans with advanced prostate cancer.

General Info

VA seeks vendor for proteomic analysis of prostate cancer biospecimens from Veterans, ensuring data security.

Agency

Department Of Veterans Affairs → 245-NETWORK Contract Office 5 (36C245)

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) View NAICS

Place of Performance

Washington, DC, 20422, USA

Set-Aside

NONE

Documents

(2)

Sources Sought Notice 36C24526Q0481 Blood Sample Protein Measurement Research

PDFsources-sought

Statement of Work for AI-Guided Blood Proteomics in Metastatic Prostate Cancer

PDFsow

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Sources Sought

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Veterans Affairs → 245-NETWORK Contract Office 5 (36C245)
Contacts1 person available
OfficeLINTHICUM, MD, 21090, USA
Organization / Agency
Department Of Veterans Affairs → 245-NETWORK Contract Office 5 (36C245)
Office AddressLINTHICUM, MD, 21090, USA
Contacts
Veronica B. Dillard

Full Description

Show more

The Washington DC VA Medical Center (DC VAMC) is conducting a prospective biospecimen collection and clinical data repository study. Advanced prostate cancer remains a leading cause of cancer morbidity and mortality among Veterans, yet validated circulating biomarkers that predict treatment response or early disease progression are lacking. Current clinical decision-making relies primarily on PSA kinetics and radiographic imaging, which have well-recognized limitations in sensitivity and lead time. The goal of the research study is to generate reproducible, high-quality proteomic data from the study’s longitudinal plasma specimens so that the VA study team can conduct exploratory analyses linking circulating proteomic changes to clinical outcomes, ultimately informing future biomarker validation studies and precision oncology strategies for Veterans with advanced prostate cancer.